Evidence map›Paper›PMID 41861819›Full record

ReviewStem cell reports2026

Diversity-in-a-dish: A practical framework for hiPSC model development.

Jesse Weidema, Hanna Lammertse, Martine de Vries, Christine Mummery, Megan Munsie, Nienke de Graeff

Abstract readReview
In one paragraph

Review in Stem cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jesse WeidemaDepartment of Medical Ethics and Health Law, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: j.j.weidema@lumc.nl.
Hanna LammertseDepartment of Anatomy and Embryology, Leiden University Medical Center, Leiden, the Netherlands; hDMT, Institute for Human Organ and Disease Model Technologies, Leiden, the Netherlands.
Martine de VriesDepartment of Medical Ethics and Health Law, Leiden University Medical Center, Leiden, the Netherlands.
Christine MummeryDepartment of Anatomy and Embryology, Leiden University Medical Center, Leiden, the Netherlands.
Megan MunsieStem Cell Medicine, Murdoch Children's Research Institute, Parkville, VIC, Australia; Melbourne Medical School, University of Melbourne, Parkville, VIC, Australia.
Nienke de GraeffDepartment of Medical Ethics and Health Law, Leiden University Medical Center, Leiden, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human induced pluripotent stem cell (hiPSC) models inherit genetic and phenotypic variation from their donors that can influence differentiation, function, and disease phenotypes, with implications for model validity and generalizability. While diversity is widely discussed in biomedical research and extensively theorized in fields like genomics, comparable guidance remains limited in hiPSC research. Effectively, diversity-related decisions are often made implicitly without clear criteria for when inclusion is methodologically warranted. We address this by (1) analyzing how diversity is defined and operationalized in (pre)clinical research, (2) extending genomics frameworks to outline stem cell-specific recommendations for describing and reporting diversity, and (3) introducing a decision framework based on four criteria (experimental purpose, biological plausibility, platform readiness, and statistical power) to determine when and how diversity should be incorporated. The overall goal is to establish a shared basis for transparent and reproducible diversity-related design and reporting.

Indexed as

Induced Pluripotent Stem CellsModels, BiologicalCell DifferentiationGenomicsHumansdiversityhuman induced pluripotent stem cellsmodel validationorganoidorgan-on-chippreclinical research

Identifiers

PMID41861819
PMCPMC13083787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.